Neurodegenerative Disease Treatment Market Report by Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Huntington’s Disease, and Others), Drug Type (N-Methyl-D-Aspartate Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Dopamine Inhibitors, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032

Neurodegenerative Disease Treatment Market Report by Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Huntington’s Disease, and Others), Drug Type (N-Methyl-D-Aspartate Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Dopamine Inhibitors, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A3102
Buy Now

1   Preface
2   Scope and Methodology

    2.1   Objectives of the Study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1   Primary Sources
        2.3.2   Secondary Sources
    2.4   Market Estimation
        2.4.1   Bottom-Up Approach
        2.4.2   Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1   Overview
    4.2   Key Industry Trends
5   Global Neurodegenerative Disease Treatment Market
    5.1   Market Overview
    5.2   Market Performance
    5.3   Impact of COVID-19
    5.4   Market Forecast
6    Market Breakup by Indication
     6.1   Multiple Sclerosis
        6.1.1  Market Trends
        6.1.2  Market Forecast
     6.2   Parkinson’s Disease
        6.2.1  Market Trends
        6.2.2  Market Forecast
     6.3   Alzheimer’s Disease
        6.3.1  Market Trends
        6.3.2  Market Forecast
     6.4   Spinal Muscular Atrophy (SMA)
        6.4.1  Market Trends
        6.4.2  Market Forecast
     6.5   Huntington’s Disease
        6.5.1  Market Trends
        6.5.2  Market Forecast
     6.6   Others
        6.6.1  Market Trends
        6.6.2  Market Forecast
7    Market Breakup by Drug Type
     7.1   N-methyl-D-aspartate Receptor Antagonists
        7.1.1  Market Trends
        7.1.2  Market Forecast
     7.2   Selective Serotonin Reuptake Inhibitors
        7.2.1  Market Trends
        7.2.2  Market Forecast
     7.3   Dopamine Inhibitors
        7.3.1  Market Trends
        7.3.2  Market Forecast
     7.4   Others
        7.4.1  Market Trends
        7.4.2  Market Forecast
8    Market Breakup by Route of Administration
     8.1   Oral
        8.1.1  Market Trends
        8.1.2  Market Forecast
     8.2   Injectable
        8.2.1  Market Trends
        8.2.2  Market Forecast
     8.3   Others
        8.3.1  Market Trends
        8.3.2  Market Forecast
9    Market Breakup by Distribution Channel
     9.1   Hospital Pharmacies
        9.1.1  Market Trends
        9.1.2  Market Forecast
     9.2   Retail Pharmacies
        9.2.1  Market Trends
        9.2.2  Market Forecast
     9.3   Others
        9.3.1  Market Trends
        9.3.2  Market Forecast
10   Market Breakup by Region
     10.1   North America
          10.1.1   United States
               10.1.1.1  Market Trends
               10.1.1.2  Market Forecast
          10.1.2   Canada
               10.1.2.1  Market Trends
               10.1.2.2  Market Forecast
     10.2   Asia-Pacific
          10.2.1   China
               10.2.1.1  Market Trends
               10.2.1.2  Market Forecast
          10.2.2   Japan
               10.2.2.1  Market Trends
               10.2.2.2  Market Forecast
          10.2.3   India
               10.2.3.1  Market Trends
               10.2.3.2  Market Forecast
          10.2.4   South Korea
               10.2.4.1  Market Trends
               10.2.4.2  Market Forecast
          10.2.5   Australia
               10.2.5.1  Market Trends
               10.2.5.2  Market Forecast
          10.2.6   Indonesia
               10.2.6.1  Market Trends
               10.2.6.2  Market Forecast
          10.2.7   Others
               10.2.7.1  Market Trends
               10.2.7.2  Market Forecast
     10.3   Europe
          10.3.1   Germany
               10.3.1.1  Market Trends
               10.3.1.2  Market Forecast
          10.3.2   France
               10.3.2.1  Market Trends
               10.3.2.2  Market Forecast
          10.3.3   United Kingdom
               10.3.3.1  Market Trends
               10.3.3.2  Market Forecast
          10.3.4   Italy
               10.3.4.1  Market Trends
               10.3.4.2  Market Forecast
          10.3.5   Spain
               10.3.5.1  Market Trends
               10.3.5.2  Market Forecast
          10.3.6   Russia
               10.3.6.1  Market Trends
               10.3.6.2  Market Forecast
          10.3.7   Others
               10.3.7.1  Market Trends
               10.3.7.2  Market Forecast
     10.4   Latin America
          10.4.1   Brazil
               10.4.1.1  Market Trends
               10.4.1.2  Market Forecast
          10.4.2   Mexico
               10.4.2.1  Market Trends
               10.4.2.2  Market Forecast
          10.4.3   Others
               10.4.3.1  Market Trends
               10.4.3.2  Market Forecast
     10.5   Middle East and Africa
          10.5.1  Market Trends
          10.5.2  Market Breakup by Country
          10.5.3  Market Forecast
11   SWOT Analysis
     11.1   Overview
     11.2   Strengths
     11.3   Weaknesses
     11.4   Opportunities
     11.5   Threats
12   Value Chain Analysis
13   Porters Five Forces Analysis

     13.1   Overview
     13.2   Bargaining Power of Buyers
     13.3   Bargaining Power of Suppliers
     13.4   Degree of Competition
     13.5   Threat of New Entrants
     13.6   Threat of Substitutes
14   Price Analysis
15   Competitive Landscape

     15.1   Market Structure
     15.2   Key Players
     15.3   Profiles of Key Players
         15.3.1   Biogen
              15.3.1.1   Company Overview
              15.3.1.2   Product Portfolio
              15.3.1.3   Financials
              15.3.1.4   SWOT Analysis
         15.3.2   Boehringer Ingelheim International GmbH
              15.3.2.1   Company Overview
              15.3.2.2   Product Portfolio
              15.3.2.3   Financials
              15.3.2.4   SWOT Analysis
         15.3.3   F. Hoffmann-La Roche AG
              15.3.3.1   Company Overview
              15.3.3.2   Product Portfolio
              15.3.3.3   Financials
         15.3.4   GlaxoSmithKline Plc 
              15.3.4.1   Company Overview
              15.3.4.2   Product Portfolio
              15.3.4.3   SWOT Analysis
         15.3.5   Merck & Co. Inc.
              15.3.5.1   Company Overview
              15.3.5.2   Product Portfolio
              15.3.5.3   Financials
              15.3.5.4   SWOT Analysis
         15.3.6   Novartis AG
              15.3.6.1   Company Overview
              15.3.6.2   Product Portfolio
              15.3.6.3   Financials
              15.3.6.4   SWOT Analysis
         15.3.7   Pfizer Inc.
              15.3.7.1   Company Overview
              15.3.7.2   Product Portfolio
              15.3.7.3   Financials
              15.3.7.4   SWOT Analysis
         15.3.8   Sanofi S.A
              15.3.8.1   Company Overview
              15.3.8.2   Product Portfolio
              15.3.8.3   Financials
              15.3.8.4   SWOT Analysis
         15.3.9   Teva Pharmaceutical Industries Ltd.
              15.3.9.1   Company Overview
              15.3.9.2   Product Portfolio
              15.3.9.3   Financials
              15.3.9.4   SWOT Analysis
         15.3.10   UCB S.A
              15.3.10.1   Company Overview
              15.3.10.2   Product Portfolio
              15.3.10.3   Financials
              15.3.10.4   SWOT Analysis

List of Figures

Figure 1: Global: Neurodegenerative Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Neurodegenerative Disease Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Neurodegenerative Disease Treatment Market: Breakup by Indication (in %), 2023
Figure 5: Global: Neurodegenerative Disease Treatment Market: Breakup by Drug Type (in %), 2023
Figure 6: Global: Neurodegenerative Disease Treatment Market: Breakup by Route of Administration (in %), 2023
Figure 7: Global: Neurodegenerative Disease Treatment Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Neurodegenerative Disease Treatment Market: Breakup by Region (in %), 2023
Figure 9: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Neurodegenerative Disease Treatment (Parkinson’s Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Neurodegenerative Disease Treatment (Parkinson’s Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Neurodegenerative Disease Treatment (Alzheimer’s Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Neurodegenerative Disease Treatment (Alzheimer’s Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Neurodegenerative Disease Treatment (Huntington’s Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Neurodegenerative Disease Treatment (Huntington’s Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Neurodegenerative Disease Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Neurodegenerative Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Neurodegenerative Disease Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Neurodegenerative Disease Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: North America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: North America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: United States: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: United States: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Canada: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Canada: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Asia-Pacific: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Asia-Pacific: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: China: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: China: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Japan: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Japan: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: India: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: India: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: South Korea: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: South Korea: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Australia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Australia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Indonesia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Indonesia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Europe: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Europe: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Germany: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Germany: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: France: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: France: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: United Kingdom: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: United Kingdom: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Italy: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Italy: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Spain: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Spain: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Russia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Russia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Latin America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Latin America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Brazil: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Brazil: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Mexico: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Mexico: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Middle East and Africa: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Middle East and Africa: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Middle East and Africa: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2023
Figure 90: Global: Neurodegenerative Disease Treatment Industry: SWOT Analysis
Figure 91: Global: Neurodegenerative Disease Treatment Industry: Value Chain Analysis
Figure 92: Global: Neurodegenerative Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurodegenerative Disease Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 3: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 4: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 5: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Neurodegenerative Disease Treatment Market: Competitive Structure
Table 8: Global: Neurodegenerative Disease Treatment Market: Key Players

Neurodegenerative Disease Treatment Market Report by Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Huntington’s Disease, and Others), Drug Type (N-Methyl-D-Aspartate Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Dopamine Inhibitors, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More